Clinical trial Recruiting at 1 site Observational Ages 18 and up

Evaluating endomyocardial biopsy and tailored treatments for inflammatory heart disease

Official title: Role of Endomyocardial Biopsy and Aetiology-based Treatment in Patients With Inflammatory Heart Disease in Arrhythmic and Non-arrhythmic Clinical Presentations: an Integrated Approach for the Optimal Diagnostic and Therapeutic Management

Run by Scientific Institute San Raffaele · NCT04521790 · Data updated 2026-11-12

This study is trying to see if a heart tissue test and personalized treatments can help people with inflammatory heart disease, especially those with myocarditis and heart rhythm issues.

More Immunosuppression trials

Quick facts

Study typeObservational
Ages18 Years and up
SexAll
Enrollment1000 (estimated)
SponsorScientific Institute San Raffaele
Academic / other
Locations1 site (Milan, Milano)
StatusRecruiting
StartedJanuary 30, 2018
Main results expectedDecember 31, 2025
Study endsDecember 31, 2035
Registry record updatedSeptember 19, 2024
Trial IDNCT04521790 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates for this study are adults aged 18 and older who have clinically suspected myocarditis.

Probably not a fit

Patients under 18 years of age or those who do not provide informed consent will not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational study investigates the role of endomyocardial biopsy (EMB) and aetiology-based treatments in patients with inflammatory heart disease, particularly focusing on myocarditis and its arrhythmic manifestations. It includes both retrospective and prospective phases, analyzing clinical data before and after myocarditis diagnosis. The study aims to compare EMB with noninvasive diagnostic techniques, assess blood biomarkers for various clinical aspects, and evaluate the healing process in different patient subgroups. By integrating multiple diagnostic and therapeutic strategies, the study seeks to optimize management for patients with myocarditis.

Why it matters

Potential benefit: If successful, this study could lead to improved diagnostic and treatment strategies for patients with inflammatory heart disease, potentially reducing morbidity and mortality.

How similar studies have gone: While the approach of using EMB in myocarditis is established, the integration of multiple diagnostic modalities and aetiology-based treatments in a multicenter setting is relatively novel.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Written informed consent.
* Age ≥ 18 years.
* Clinically suspected myocarditis.
* Enrollment performed by one of the participating Centers.

Exclusion Criteria:

* Absence of written informed consent.
* Age \< 18 years (paediatric population).

Where it's running

  • IRCCS San Raffaele Scientific Institute
    Milan, Milano, Italy
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.